36800238|t|The anti-caspase 1 inhibitor VX-765 reduces immune activation, CD4+ T cell depletion, viral load, and total HIV-1 DNA in HIV-1 infected humanized mice.
36800238|a|HIV-1 infection results in the activation of inflammasome that may facilitate viral spread and establishment of viral reservoirs. We evaluated the effects of the caspase-1 inhibitor VX-765 on HIV-1 infection in humanized NSG mice engrafted with human CD34+ hematopoietic stem cells. Expression of caspase-1, NLRP3, and IL-1beta was increased in lymph nodes and bone marrow between day 1 and 3 after HIV-1 infection (mean fold change (FC) of 2.08, 3.23, and 6.05, p<0.001, respectively). IFI16 and AIM2 expression peaked at day 24 and coincides with increased IL-18 levels (6.89 vs 83.19 pg/ml, p=0.004), increased viral load and CD4+ T cells loss in blood (p<0.005 and p<0.0001, for the spleen respectively). Treatment with VX-765 significantly reduced TNF-alpha at day 11 (0.47 vs 2.2 pg/ml, p=0.045), IL-18 at day 22 (7.8 vs 23.2 pg/ml, p=0.04), CD4+ T cells (44.3% vs 36,7%, p=0.01), viral load (4.26 vs 4.89 log 10 copies/ml, p=0.027), and total HIV-1 DNA in the spleen (1 054 vs 2 889 copies /106 cells, p=0.029). We demonstrated that targeting inflammasome activation early after infection may represent a therapeutic strategy towards HIV cure to prevent CD4+ T cell depletion and reduce immune activation, viral load, and the HIV-1 reservoir formation.
36800238	9	18	caspase 1	Gene	834
36800238	29	35	VX-765	Chemical	MESH:C520022
36800238	63	66	CD4	Gene	12504
36800238	108	113	HIV-1	Species	11676
36800238	121	135	HIV-1 infected	Disease	MESH:D015658
36800238	146	150	mice	Species	10090
36800238	152	167	HIV-1 infection	Disease	MESH:D015658
36800238	314	323	caspase-1	Gene	834
36800238	334	340	VX-765	Chemical	MESH:C520022
36800238	344	359	HIV-1 infection	Species	
36800238	377	381	mice	Species	10090
36800238	397	402	human	Species	9606
36800238	403	407	CD34	Gene	947
36800238	449	458	caspase-1	Gene	834
36800238	460	465	NLRP3	Gene	114548
36800238	471	479	IL-1beta	Gene	3553
36800238	551	566	HIV-1 infection	Species	
36800238	639	644	IFI16	Gene	15951
36800238	649	653	AIM2	Gene	9447
36800238	711	716	IL-18	Gene	16173
36800238	781	784	CD4	Gene	12504
36800238	876	882	VX-765	Chemical	MESH:C520022
36800238	905	914	TNF-alpha	Gene	21926
36800238	955	960	IL-18	Gene	16173
36800238	1000	1003	CD4	Gene	12504
36800238	1102	1107	HIV-1	Species	11676
36800238	1238	1247	infection	Disease	MESH:D007239
36800238	1293	1296	HIV	Species	11676
36800238	1313	1316	CD4	Gene	12504
36800238	1385	1390	HIV-1	Species	11676
36800238	Negative_Correlation	MESH:C520022	21926
36800238	Negative_Correlation	MESH:C520022	12504
36800238	Negative_Correlation	MESH:C520022	16173
36800238	Negative_Correlation	MESH:C520022	15951
36800238	Positive_Correlation	16173	9447
36800238	Negative_Correlation	MESH:C520022	MESH:D015658
36800238	Negative_Correlation	MESH:C520022	834
36800238	Positive_Correlation	15951	16173

